nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—prostate cancer—urinary bladder cancer	0.289	1	CtDrD
Estramustine—Alkylating Activity—Mitomycin—urinary bladder cancer	0.239	0.569	CiPCiCtD
Estramustine—Alkylating Activity—Thiotepa—urinary bladder cancer	0.181	0.431	CiPCiCtD
Estramustine—ESR2—urinary bladder cancer	0.118	0.619	CbGaD
Estramustine—ESR1—urinary bladder cancer	0.0726	0.381	CbGaD
Estramustine—ABCB1—Mitomycin—urinary bladder cancer	0.018	0.379	CbGbCtD
Estramustine—CYP3A4—Thiotepa—urinary bladder cancer	0.00818	0.172	CbGbCtD
Estramustine—ABCB1—Gemcitabine—urinary bladder cancer	0.00518	0.109	CbGbCtD
Estramustine—ABCB1—Cisplatin—urinary bladder cancer	0.00377	0.0792	CbGbCtD
Estramustine—ABCB1—Etoposide—urinary bladder cancer	0.0037	0.0778	CbGbCtD
Estramustine—ABCB1—Doxorubicin—urinary bladder cancer	0.00252	0.0531	CbGbCtD
Estramustine—ABCB1—Methotrexate—urinary bladder cancer	0.00245	0.0514	CbGbCtD
Estramustine—CYP3A4—Etoposide—urinary bladder cancer	0.00222	0.0466	CbGbCtD
Estramustine—MAP1A—prostate gland—urinary bladder cancer	0.00163	0.116	CbGeAlD
Estramustine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00151	0.0318	CbGbCtD
Estramustine—MAP1A—smooth muscle tissue—urinary bladder cancer	0.00115	0.0824	CbGeAlD
Estramustine—MAP2—prostate gland—urinary bladder cancer	0.000926	0.0661	CbGeAlD
Estramustine—MAP1A—vagina—urinary bladder cancer	0.000804	0.0574	CbGeAlD
Estramustine—MAP2—seminal vesicle—urinary bladder cancer	0.000783	0.0559	CbGeAlD
Estramustine—CYP3A4—urine—urinary bladder cancer	0.000639	0.0456	CbGeAlD
Estramustine—MAP2—urethra—urinary bladder cancer	0.00062	0.0443	CbGeAlD
Estramustine—ESR2—prostate gland—urinary bladder cancer	0.0006	0.0428	CbGeAlD
Estramustine—MAP1A—lymph node—urinary bladder cancer	0.00052	0.0371	CbGeAlD
Estramustine—MAP2—female reproductive system—urinary bladder cancer	0.000505	0.0361	CbGeAlD
Estramustine—MAP2—vagina—urinary bladder cancer	0.000457	0.0326	CbGeAlD
Estramustine—ESR2—epithelium—urinary bladder cancer	0.000441	0.0315	CbGeAlD
Estramustine—ESR2—smooth muscle tissue—urinary bladder cancer	0.000425	0.0303	CbGeAlD
Estramustine—ESR1—prostate gland—urinary bladder cancer	0.000411	0.0293	CbGeAlD
Estramustine—ESR2—renal system—urinary bladder cancer	0.000409	0.0292	CbGeAlD
Estramustine—ESR2—female reproductive system—urinary bladder cancer	0.000327	0.0234	CbGeAlD
Estramustine—ESR1—epithelium—urinary bladder cancer	0.000302	0.0216	CbGeAlD
Estramustine—ESR2—vagina—urinary bladder cancer	0.000296	0.0211	CbGeAlD
Estramustine—MAP2—lymph node—urinary bladder cancer	0.000296	0.0211	CbGeAlD
Estramustine—ESR1—smooth muscle tissue—urinary bladder cancer	0.000291	0.0208	CbGeAlD
Estramustine—ESR1—renal system—urinary bladder cancer	0.00028	0.02	CbGeAlD
Estramustine—ESR1—female reproductive system—urinary bladder cancer	0.000224	0.016	CbGeAlD
Estramustine—Estriol—ESR2—urinary bladder cancer	0.000218	0.133	CrCbGaD
Estramustine—Quinestrol—ESR1—urinary bladder cancer	0.000203	0.124	CrCbGaD
Estramustine—ESR1—vagina—urinary bladder cancer	0.000203	0.0145	CbGeAlD
Estramustine—Tenderness—Cisplatin—urinary bladder cancer	0.000192	0.00774	CcSEcCtD
Estramustine—ESR2—lymph node—urinary bladder cancer	0.000192	0.0137	CbGeAlD
Estramustine—Lacrimation increased—Fluorouracil—urinary bladder cancer	0.000191	0.00773	CcSEcCtD
Estramustine—Alopecia—Mitomycin—urinary bladder cancer	0.000188	0.0076	CcSEcCtD
Estramustine—Myelosuppression—Epirubicin—urinary bladder cancer	0.000183	0.00739	CcSEcCtD
Estramustine—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.000171	0.00691	CcSEcCtD
Estramustine—Embolism venous—Epirubicin—urinary bladder cancer	0.00017	0.00687	CcSEcCtD
Estramustine—Myelosuppression—Doxorubicin—urinary bladder cancer	0.000169	0.00684	CcSEcCtD
Estramustine—Estropipate—ESR2—urinary bladder cancer	0.000167	0.102	CrCbGaD
Estramustine—Leukopenia—Mitomycin—urinary bladder cancer	0.000166	0.0067	CcSEcCtD
Estramustine—Hypernatraemia—Epirubicin—urinary bladder cancer	0.000163	0.00659	CcSEcCtD
Estramustine—ABCB1—prostate gland—urinary bladder cancer	0.000162	0.0116	CbGeAlD
Estramustine—Skin exfoliation—Cisplatin—urinary bladder cancer	0.00016	0.00644	CcSEcCtD
Estramustine—Embolism venous—Doxorubicin—urinary bladder cancer	0.000157	0.00636	CcSEcCtD
Estramustine—CYP3A4—renal system—urinary bladder cancer	0.000156	0.0112	CbGeAlD
Estramustine—Pruritus—Valrubicin—urinary bladder cancer	0.000155	0.00627	CcSEcCtD
Estramustine—Mestranol—ESR1—urinary bladder cancer	0.000154	0.0942	CrCbGaD
Estramustine—Oedema—Mitomycin—urinary bladder cancer	0.000151	0.00611	CcSEcCtD
Estramustine—Hypernatraemia—Doxorubicin—urinary bladder cancer	0.000151	0.0061	CcSEcCtD
Estramustine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00015	0.00607	CcSEcCtD
Estramustine—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.000148	0.00598	CcSEcCtD
Estramustine—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.000148	0.00597	CcSEcCtD
Estramustine—Cardiac arrest—Thiotepa—urinary bladder cancer	0.000147	0.00594	CcSEcCtD
Estramustine—Skin exfoliation—Etoposide—urinary bladder cancer	0.000146	0.0059	CcSEcCtD
Estramustine—Lacrimation—Epirubicin—urinary bladder cancer	0.000146	0.00589	CcSEcCtD
Estramustine—Anorexia—Mitomycin—urinary bladder cancer	0.000144	0.00582	CcSEcCtD
Estramustine—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.000144	0.0058	CcSEcCtD
Estramustine—Embolism—Methotrexate—urinary bladder cancer	0.000143	0.00577	CcSEcCtD
Estramustine—Vomiting—Valrubicin—urinary bladder cancer	0.00014	0.00564	CcSEcCtD
Estramustine—Rash—Valrubicin—urinary bladder cancer	0.000138	0.00559	CcSEcCtD
Estramustine—Dermatitis—Valrubicin—urinary bladder cancer	0.000138	0.00558	CcSEcCtD
Estramustine—Headache—Valrubicin—urinary bladder cancer	0.000138	0.00555	CcSEcCtD
Estramustine—ABCB1—seminal vesicle—urinary bladder cancer	0.000137	0.0098	CbGeAlD
Estramustine—Lacrimation—Doxorubicin—urinary bladder cancer	0.000135	0.00545	CcSEcCtD
Estramustine—Dyspnoea—Mitomycin—urinary bladder cancer	0.000135	0.00544	CcSEcCtD
Estramustine—Estriol—ESR1—urinary bladder cancer	0.000134	0.0822	CrCbGaD
Estramustine—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.000134	0.0054	CcSEcCtD
Estramustine—Embolism—Epirubicin—urinary bladder cancer	0.000134	0.0054	CcSEcCtD
Estramustine—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.000133	0.00536	CcSEcCtD
Estramustine—Decreased appetite—Mitomycin—urinary bladder cancer	0.000131	0.00531	CcSEcCtD
Estramustine—ESR1—lymph node—urinary bladder cancer	0.000131	0.00937	CbGeAlD
Estramustine—Lethargy—Fluorouracil—urinary bladder cancer	0.000131	0.00527	CcSEcCtD
Estramustine—Nausea—Valrubicin—urinary bladder cancer	0.00013	0.00527	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.000128	0.00517	CcSEcCtD
Estramustine—Pancytopenia—Thiotepa—urinary bladder cancer	0.000127	0.00513	CcSEcCtD
Estramustine—CYP3A4—female reproductive system—urinary bladder cancer	0.000125	0.00894	CbGeAlD
Estramustine—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.000124	0.005	CcSEcCtD
Estramustine—Embolism—Doxorubicin—urinary bladder cancer	0.000124	0.005	CcSEcCtD
Estramustine—Hypercalcaemia—Epirubicin—urinary bladder cancer	0.000124	0.00499	CcSEcCtD
Estramustine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.000123	0.00495	CcSEcCtD
Estramustine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.000122	0.00491	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.000121	0.0049	CcSEcCtD
Estramustine—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00012	0.00485	CcSEcCtD
Estramustine—ABCB1—epithelium—urinary bladder cancer	0.000119	0.00851	CbGeAlD
Estramustine—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000119	0.0729	CrCbGaD
Estramustine—Dry skin—Fluorouracil—urinary bladder cancer	0.000117	0.00474	CcSEcCtD
Estramustine—Hypercalcaemia—Doxorubicin—urinary bladder cancer	0.000114	0.00462	CcSEcCtD
Estramustine—ABCB1—renal system—urinary bladder cancer	0.000111	0.0079	CbGeAlD
Estramustine—ABCB1—urethra—urinary bladder cancer	0.000109	0.00776	CbGeAlD
Estramustine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000107	0.00431	CcSEcCtD
Estramustine—Cardiac arrest—Etoposide—urinary bladder cancer	0.000106	0.00427	CcSEcCtD
Estramustine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000105	0.00424	CcSEcCtD
Estramustine—Dysphonia—Epirubicin—urinary bladder cancer	0.000104	0.00421	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR2—urinary bladder cancer	0.000104	0.0636	CrCbGaD
Estramustine—Estrone—ESR2—urinary bladder cancer	0.000104	0.0635	CrCbGaD
Estramustine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000104	0.00418	CcSEcCtD
Estramustine—Estropipate—ESR1—urinary bladder cancer	0.000103	0.0628	CrCbGaD
Estramustine—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000101	0.00406	CcSEcCtD
Estramustine—Tinnitus—Thiotepa—urinary bladder cancer	9.98e-05	0.00403	CcSEcCtD
Estramustine—Pancytopenia—Cisplatin—urinary bladder cancer	9.96e-05	0.00402	CcSEcCtD
Estramustine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	9.89e-05	0.00399	CcSEcCtD
Estramustine—Myocardial infarction—Gemcitabine—urinary bladder cancer	9.84e-05	0.00397	CcSEcCtD
Estramustine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	9.73e-05	0.00393	CcSEcCtD
Estramustine—Myocardial infarction—Fluorouracil—urinary bladder cancer	9.67e-05	0.0039	CcSEcCtD
Estramustine—Dysphonia—Doxorubicin—urinary bladder cancer	9.66e-05	0.0039	CcSEcCtD
Estramustine—Vomiting—Mitomycin—urinary bladder cancer	9.62e-05	0.00388	CcSEcCtD
Estramustine—Rash—Mitomycin—urinary bladder cancer	9.54e-05	0.00385	CcSEcCtD
Estramustine—Dermatitis—Mitomycin—urinary bladder cancer	9.53e-05	0.00385	CcSEcCtD
Estramustine—Headache—Mitomycin—urinary bladder cancer	9.48e-05	0.00383	CcSEcCtD
Estramustine—Alopecia—Thiotepa—urinary bladder cancer	9.46e-05	0.00382	CcSEcCtD
Estramustine—Lacrimation increased—Epirubicin—urinary bladder cancer	9.32e-05	0.00376	CcSEcCtD
Estramustine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	9.22e-05	0.00372	CcSEcCtD
Estramustine—Myocardial infarction—Cisplatin—urinary bladder cancer	9.17e-05	0.0037	CcSEcCtD
Estramustine—Pancytopenia—Etoposide—urinary bladder cancer	9.13e-05	0.00368	CcSEcCtD
Estramustine—Nausea—Mitomycin—urinary bladder cancer	8.99e-05	0.00363	CcSEcCtD
Estramustine—ABCB1—female reproductive system—urinary bladder cancer	8.86e-05	0.00633	CbGeAlD
Estramustine—Skin exfoliation—Methotrexate—urinary bladder cancer	8.76e-05	0.00354	CcSEcCtD
Estramustine—Lacrimation increased—Doxorubicin—urinary bladder cancer	8.62e-05	0.00348	CcSEcCtD
Estramustine—Acute coronary syndrome—Etoposide—urinary bladder cancer	8.45e-05	0.00341	CcSEcCtD
Estramustine—Myocardial infarction—Etoposide—urinary bladder cancer	8.4e-05	0.00339	CcSEcCtD
Estramustine—Leukopenia—Thiotepa—urinary bladder cancer	8.34e-05	0.00337	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—urinary bladder cancer	8.21e-05	0.00331	CcSEcCtD
Estramustine—Skin exfoliation—Epirubicin—urinary bladder cancer	8.2e-05	0.00331	CcSEcCtD
Estramustine—ABCB1—vagina—urinary bladder cancer	8.01e-05	0.00572	CbGeAlD
Estramustine—Alopecia—Gemcitabine—urinary bladder cancer	7.96e-05	0.00321	CcSEcCtD
Estramustine—Anxiety—Thiotepa—urinary bladder cancer	7.91e-05	0.00319	CcSEcCtD
Estramustine—Cramps of lower extremities—Epirubicin—urinary bladder cancer	7.89e-05	0.00318	CcSEcCtD
Estramustine—Estradiol—ESR2—urinary bladder cancer	7.86e-05	0.0481	CrCbGaD
Estramustine—Tinnitus—Cisplatin—urinary bladder cancer	7.83e-05	0.00316	CcSEcCtD
Estramustine—Alopecia—Fluorouracil—urinary bladder cancer	7.83e-05	0.00316	CcSEcCtD
Estramustine—Flushing—Cisplatin—urinary bladder cancer	7.79e-05	0.00315	CcSEcCtD
Estramustine—Thrombophlebitis—Methotrexate—urinary bladder cancer	7.69e-05	0.00311	CcSEcCtD
Estramustine—Skin exfoliation—Doxorubicin—urinary bladder cancer	7.58e-05	0.00306	CcSEcCtD
Estramustine—Thrombocytopenia—Thiotepa—urinary bladder cancer	7.45e-05	0.00301	CcSEcCtD
Estramustine—Alopecia—Cisplatin—urinary bladder cancer	7.42e-05	0.003	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR1—urinary bladder cancer	7.34e-05	0.0449	CrCbGaD
Estramustine—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	7.3e-05	0.00295	CcSEcCtD
Estramustine—Anorexia—Thiotepa—urinary bladder cancer	7.25e-05	0.00293	CcSEcCtD
Estramustine—Flatulence—Cisplatin—urinary bladder cancer	7.2e-05	0.00291	CcSEcCtD
Estramustine—Thrombophlebitis—Epirubicin—urinary bladder cancer	7.2e-05	0.00291	CcSEcCtD
Estramustine—Flushing—Etoposide—urinary bladder cancer	7.14e-05	0.00288	CcSEcCtD
Estramustine—Muscle spasms—Cisplatin—urinary bladder cancer	7.03e-05	0.00284	CcSEcCtD
Estramustine—Leukopenia—Gemcitabine—urinary bladder cancer	7.02e-05	0.00283	CcSEcCtD
Estramustine—Eye pain—Epirubicin—urinary bladder cancer	6.9e-05	0.00279	CcSEcCtD
Estramustine—Leukopenia—Fluorouracil—urinary bladder cancer	6.9e-05	0.00279	CcSEcCtD
Estramustine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	6.87e-05	0.00277	CcSEcCtD
Estramustine—Alopecia—Etoposide—urinary bladder cancer	6.8e-05	0.00274	CcSEcCtD
Estramustine—Lethargy—Methotrexate—urinary bladder cancer	6.8e-05	0.00274	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—urinary bladder cancer	6.8e-05	0.00274	CcSEcCtD
Estramustine—Chest pain—Gemcitabine—urinary bladder cancer	6.68e-05	0.0027	CcSEcCtD
Estramustine—Hot flush—Epirubicin—urinary bladder cancer	6.66e-05	0.00269	CcSEcCtD
Estramustine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	6.66e-05	0.00269	CcSEcCtD
Estramustine—Decreased appetite—Thiotepa—urinary bladder cancer	6.61e-05	0.00267	CcSEcCtD
Estramustine—Menopausal symptoms—Epirubicin—urinary bladder cancer	6.6e-05	0.00267	CcSEcCtD
Estramustine—Chest pain—Fluorouracil—urinary bladder cancer	6.56e-05	0.00265	CcSEcCtD
Estramustine—Leukopenia—Cisplatin—urinary bladder cancer	6.54e-05	0.00264	CcSEcCtD
Estramustine—Muscle spasms—Etoposide—urinary bladder cancer	6.44e-05	0.0026	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR1—urinary bladder cancer	6.41e-05	0.0392	CrCbGaD
Estramustine—Oedema—Gemcitabine—urinary bladder cancer	6.4e-05	0.00258	CcSEcCtD
Estramustine—Estrone—ESR1—urinary bladder cancer	6.39e-05	0.0391	CrCbGaD
Estramustine—Eye pain—Doxorubicin—urinary bladder cancer	6.39e-05	0.00258	CcSEcCtD
Estramustine—Lethargy—Epirubicin—urinary bladder cancer	6.36e-05	0.00257	CcSEcCtD
Estramustine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	6.36e-05	0.00257	CcSEcCtD
Estramustine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	6.36e-05	0.00257	CcSEcCtD
Estramustine—Mood swings—Methotrexate—urinary bladder cancer	6.31e-05	0.00255	CcSEcCtD
Estramustine—Oedema—Fluorouracil—urinary bladder cancer	6.29e-05	0.00254	CcSEcCtD
Estramustine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	6.27e-05	0.00253	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	6.23e-05	0.00252	CcSEcCtD
Estramustine—Anxiety—Cisplatin—urinary bladder cancer	6.2e-05	0.0025	CcSEcCtD
Estramustine—Hot flush—Doxorubicin—urinary bladder cancer	6.16e-05	0.00249	CcSEcCtD
Estramustine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	6.16e-05	0.00249	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—urinary bladder cancer	6.15e-05	0.00248	CcSEcCtD
Estramustine—Affect lability—Epirubicin—urinary bladder cancer	6.13e-05	0.00248	CcSEcCtD
Estramustine—Menopausal symptoms—Doxorubicin—urinary bladder cancer	6.11e-05	0.00247	CcSEcCtD
Estramustine—Anorexia—Gemcitabine—urinary bladder cancer	6.1e-05	0.00246	CcSEcCtD
Estramustine—Anorexia—Fluorouracil—urinary bladder cancer	6e-05	0.00242	CcSEcCtD
Estramustine—Leukopenia—Etoposide—urinary bladder cancer	5.99e-05	0.00242	CcSEcCtD
Estramustine—Oedema—Cisplatin—urinary bladder cancer	5.96e-05	0.00241	CcSEcCtD
Estramustine—Cardiac arrest—Epirubicin—urinary bladder cancer	5.93e-05	0.00239	CcSEcCtD
Estramustine—Mood swings—Epirubicin—urinary bladder cancer	5.9e-05	0.00238	CcSEcCtD
Estramustine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	5.88e-05	0.00238	CcSEcCtD
Estramustine—Lethargy—Doxorubicin—urinary bladder cancer	5.88e-05	0.00238	CcSEcCtD
Estramustine—Thrombocytopenia—Cisplatin—urinary bladder cancer	5.84e-05	0.00236	CcSEcCtD
Estramustine—Insomnia—Gemcitabine—urinary bladder cancer	5.79e-05	0.00234	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	5.77e-05	0.00233	CcSEcCtD
Estramustine—Liver function test abnormal—Epirubicin—urinary bladder cancer	5.75e-05	0.00232	CcSEcCtD
Estramustine—Dry skin—Epirubicin—urinary bladder cancer	5.71e-05	0.00231	CcSEcCtD
Estramustine—Dyspnoea—Gemcitabine—urinary bladder cancer	5.71e-05	0.0023	CcSEcCtD
Estramustine—Chest pain—Etoposide—urinary bladder cancer	5.7e-05	0.0023	CcSEcCtD
Estramustine—Insomnia—Fluorouracil—urinary bladder cancer	5.69e-05	0.0023	CcSEcCtD
Estramustine—Anorexia—Cisplatin—urinary bladder cancer	5.69e-05	0.0023	CcSEcCtD
Estramustine—Affect lability—Doxorubicin—urinary bladder cancer	5.68e-05	0.00229	CcSEcCtD
Estramustine—Dyspnoea—Fluorouracil—urinary bladder cancer	5.61e-05	0.00226	CcSEcCtD
Estramustine—Decreased appetite—Gemcitabine—urinary bladder cancer	5.56e-05	0.00225	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—urinary bladder cancer	5.52e-05	0.00223	CcSEcCtD
Estramustine—Cardiac arrest—Doxorubicin—urinary bladder cancer	5.48e-05	0.00221	CcSEcCtD
Estramustine—Decreased appetite—Fluorouracil—urinary bladder cancer	5.47e-05	0.00221	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—urinary bladder cancer	5.47e-05	0.00221	CcSEcCtD
Estramustine—Mood swings—Doxorubicin—urinary bladder cancer	5.46e-05	0.00221	CcSEcCtD
Estramustine—Pruritus—Thiotepa—urinary bladder cancer	5.38e-05	0.00217	CcSEcCtD
Estramustine—Thrombocytopenia—Etoposide—urinary bladder cancer	5.35e-05	0.00216	CcSEcCtD
Estramustine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	5.32e-05	0.00215	CcSEcCtD
Estramustine—Dyspnoea—Cisplatin—urinary bladder cancer	5.32e-05	0.00215	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—urinary bladder cancer	5.3e-05	0.00214	CcSEcCtD
Estramustine—Dry skin—Doxorubicin—urinary bladder cancer	5.29e-05	0.00213	CcSEcCtD
Estramustine—Anorexia—Etoposide—urinary bladder cancer	5.21e-05	0.0021	CcSEcCtD
Estramustine—Diarrhoea—Thiotepa—urinary bladder cancer	5.21e-05	0.0021	CcSEcCtD
Estramustine—Decreased appetite—Cisplatin—urinary bladder cancer	5.19e-05	0.00209	CcSEcCtD
Estramustine—ABCB1—lymph node—urinary bladder cancer	5.18e-05	0.0037	CbGeAlD
Estramustine—Depression—Methotrexate—urinary bladder cancer	5.12e-05	0.00207	CcSEcCtD
Estramustine—Pancytopenia—Epirubicin—urinary bladder cancer	5.12e-05	0.00207	CcSEcCtD
Estramustine—Dyspnoea—Etoposide—urinary bladder cancer	4.87e-05	0.00197	CcSEcCtD
Estramustine—Estradiol—ESR1—urinary bladder cancer	4.84e-05	0.0296	CrCbGaD
Estramustine—Vomiting—Thiotepa—urinary bladder cancer	4.84e-05	0.00195	CcSEcCtD
Estramustine—Rash—Thiotepa—urinary bladder cancer	4.8e-05	0.00194	CcSEcCtD
Estramustine—Dermatitis—Thiotepa—urinary bladder cancer	4.79e-05	0.00193	CcSEcCtD
Estramustine—Headache—Thiotepa—urinary bladder cancer	4.77e-05	0.00192	CcSEcCtD
Estramustine—Decreased appetite—Etoposide—urinary bladder cancer	4.75e-05	0.00192	CcSEcCtD
Estramustine—Pancytopenia—Doxorubicin—urinary bladder cancer	4.73e-05	0.00191	CcSEcCtD
Estramustine—Pruritus—Gemcitabine—urinary bladder cancer	4.53e-05	0.00183	CcSEcCtD
Estramustine—Nausea—Thiotepa—urinary bladder cancer	4.52e-05	0.00182	CcSEcCtD
Estramustine—Pruritus—Fluorouracil—urinary bladder cancer	4.45e-05	0.0018	CcSEcCtD
Estramustine—Diarrhoea—Gemcitabine—urinary bladder cancer	4.38e-05	0.00177	CcSEcCtD
Estramustine—Diarrhoea—Fluorouracil—urinary bladder cancer	4.31e-05	0.00174	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—urinary bladder cancer	4.3e-05	0.00173	CcSEcCtD
Estramustine—Diarrhoea—Cisplatin—urinary bladder cancer	4.08e-05	0.00165	CcSEcCtD
Estramustine—Alopecia—Methotrexate—urinary bladder cancer	4.07e-05	0.00164	CcSEcCtD
Estramustine—Vomiting—Gemcitabine—urinary bladder cancer	4.07e-05	0.00164	CcSEcCtD
Estramustine—Rash—Gemcitabine—urinary bladder cancer	4.03e-05	0.00163	CcSEcCtD
Estramustine—Dermatitis—Gemcitabine—urinary bladder cancer	4.03e-05	0.00163	CcSEcCtD
Estramustine—Tinnitus—Epirubicin—urinary bladder cancer	4.02e-05	0.00162	CcSEcCtD
Estramustine—Headache—Gemcitabine—urinary bladder cancer	4.01e-05	0.00162	CcSEcCtD
Estramustine—Flushing—Epirubicin—urinary bladder cancer	4e-05	0.00162	CcSEcCtD
Estramustine—Vomiting—Fluorouracil—urinary bladder cancer	4e-05	0.00162	CcSEcCtD
Estramustine—Rash—Fluorouracil—urinary bladder cancer	3.97e-05	0.0016	CcSEcCtD
Estramustine—Dermatitis—Fluorouracil—urinary bladder cancer	3.96e-05	0.0016	CcSEcCtD
Estramustine—Headache—Fluorouracil—urinary bladder cancer	3.94e-05	0.00159	CcSEcCtD
Estramustine—Pruritus—Etoposide—urinary bladder cancer	3.87e-05	0.00156	CcSEcCtD
Estramustine—Alopecia—Epirubicin—urinary bladder cancer	3.81e-05	0.00154	CcSEcCtD
Estramustine—Nausea—Gemcitabine—urinary bladder cancer	3.8e-05	0.00153	CcSEcCtD
Estramustine—Vomiting—Cisplatin—urinary bladder cancer	3.79e-05	0.00153	CcSEcCtD
Estramustine—Rash—Cisplatin—urinary bladder cancer	3.76e-05	0.00152	CcSEcCtD
Estramustine—Dermatitis—Cisplatin—urinary bladder cancer	3.76e-05	0.00152	CcSEcCtD
Estramustine—Diarrhoea—Etoposide—urinary bladder cancer	3.74e-05	0.00151	CcSEcCtD
Estramustine—Nausea—Fluorouracil—urinary bladder cancer	3.74e-05	0.00151	CcSEcCtD
Estramustine—Tinnitus—Doxorubicin—urinary bladder cancer	3.72e-05	0.0015	CcSEcCtD
Estramustine—Flushing—Doxorubicin—urinary bladder cancer	3.7e-05	0.00149	CcSEcCtD
Estramustine—Flatulence—Epirubicin—urinary bladder cancer	3.7e-05	0.00149	CcSEcCtD
Estramustine—Muscle spasms—Epirubicin—urinary bladder cancer	3.61e-05	0.00146	CcSEcCtD
Estramustine—Leukopenia—Methotrexate—urinary bladder cancer	3.59e-05	0.00145	CcSEcCtD
Estramustine—Nausea—Cisplatin—urinary bladder cancer	3.54e-05	0.00143	CcSEcCtD
Estramustine—Alopecia—Doxorubicin—urinary bladder cancer	3.53e-05	0.00142	CcSEcCtD
Estramustine—Vomiting—Etoposide—urinary bladder cancer	3.47e-05	0.0014	CcSEcCtD
Estramustine—Rash—Etoposide—urinary bladder cancer	3.45e-05	0.00139	CcSEcCtD
Estramustine—Dermatitis—Etoposide—urinary bladder cancer	3.44e-05	0.00139	CcSEcCtD
Estramustine—Headache—Etoposide—urinary bladder cancer	3.42e-05	0.00138	CcSEcCtD
Estramustine—Flatulence—Doxorubicin—urinary bladder cancer	3.42e-05	0.00138	CcSEcCtD
Estramustine—Chest pain—Methotrexate—urinary bladder cancer	3.41e-05	0.00138	CcSEcCtD
Estramustine—Leukopenia—Epirubicin—urinary bladder cancer	3.36e-05	0.00136	CcSEcCtD
Estramustine—Muscle spasms—Doxorubicin—urinary bladder cancer	3.34e-05	0.00135	CcSEcCtD
Estramustine—Nausea—Etoposide—urinary bladder cancer	3.25e-05	0.00131	CcSEcCtD
Estramustine—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.2e-05	0.00129	CcSEcCtD
Estramustine—Chest pain—Epirubicin—urinary bladder cancer	3.2e-05	0.00129	CcSEcCtD
Estramustine—Anxiety—Epirubicin—urinary bladder cancer	3.18e-05	0.00129	CcSEcCtD
Estramustine—Anorexia—Methotrexate—urinary bladder cancer	3.12e-05	0.00126	CcSEcCtD
Estramustine—Leukopenia—Doxorubicin—urinary bladder cancer	3.11e-05	0.00125	CcSEcCtD
Estramustine—Oedema—Epirubicin—urinary bladder cancer	3.06e-05	0.00124	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	3.04e-05	0.00235	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.04e-05	0.00234	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	3.03e-05	0.00234	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3e-05	0.00231	CbGpPWpGaD
Estramustine—Thrombocytopenia—Epirubicin—urinary bladder cancer	3e-05	0.00121	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	3e-05	0.00231	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	3e-05	0.00231	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	2.97e-05	0.00229	CbGpPWpGaD
Estramustine—Insomnia—Methotrexate—urinary bladder cancer	2.96e-05	0.0012	CcSEcCtD
Estramustine—Chest pain—Doxorubicin—urinary bladder cancer	2.96e-05	0.00119	CcSEcCtD
Estramustine—Anxiety—Doxorubicin—urinary bladder cancer	2.95e-05	0.00119	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	2.93e-05	0.00226	CbGpPWpGaD
Estramustine—Anorexia—Epirubicin—urinary bladder cancer	2.92e-05	0.00118	CcSEcCtD
Estramustine—Dyspnoea—Methotrexate—urinary bladder cancer	2.92e-05	0.00118	CcSEcCtD
Estramustine—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	2.92e-05	0.00225	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	2.92e-05	0.00225	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	2.9e-05	0.00224	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	2.9e-05	0.00224	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	2.88e-05	0.00222	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	2.88e-05	0.00222	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	2.88e-05	0.00222	CbGpPWpGaD
Estramustine—Decreased appetite—Methotrexate—urinary bladder cancer	2.85e-05	0.00115	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	2.84e-05	0.00219	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	2.84e-05	0.00219	CbGpPWpGaD
Estramustine—Oedema—Doxorubicin—urinary bladder cancer	2.83e-05	0.00114	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	2.78e-05	0.00214	CbGpPWpGaD
Estramustine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.78e-05	0.00112	CcSEcCtD
Estramustine—Insomnia—Epirubicin—urinary bladder cancer	2.77e-05	0.00112	CcSEcCtD
Estramustine—Dyspnoea—Epirubicin—urinary bladder cancer	2.73e-05	0.0011	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	2.72e-05	0.0021	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	2.72e-05	0.00209	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	2.71e-05	0.00209	CbGpPWpGaD
Estramustine—Anorexia—Doxorubicin—urinary bladder cancer	2.7e-05	0.00109	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	2.67e-05	0.00206	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	2.67e-05	0.00206	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	2.67e-05	0.00206	CbGpPWpGaD
Estramustine—Decreased appetite—Epirubicin—urinary bladder cancer	2.66e-05	0.00108	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	2.66e-05	0.00205	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	2.65e-05	0.00204	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	2.63e-05	0.00203	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	2.63e-05	0.00202	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	2.6e-05	0.002	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	2.59e-05	0.002	CbGpPWpGaD
Estramustine—Insomnia—Doxorubicin—urinary bladder cancer	2.56e-05	0.00103	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.55e-05	0.00196	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	2.53e-05	0.00195	CbGpPWpGaD
Estramustine—Dyspnoea—Doxorubicin—urinary bladder cancer	2.53e-05	0.00102	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	2.5e-05	0.00193	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	2.5e-05	0.00193	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.49e-05	0.00192	CbGpPWpGaD
Estramustine—Decreased appetite—Doxorubicin—urinary bladder cancer	2.46e-05	0.000995	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	2.46e-05	0.0019	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	2.46e-05	0.00189	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	2.45e-05	0.00189	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	2.44e-05	0.00188	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	2.43e-05	0.00188	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	2.43e-05	0.00187	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	2.4e-05	0.00185	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	2.4e-05	0.00185	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	2.37e-05	0.00183	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	2.33e-05	0.0018	CbGpPWpGaD
Estramustine—Pruritus—Methotrexate—urinary bladder cancer	2.32e-05	0.000935	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	2.29e-05	0.00177	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	2.25e-05	0.00174	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.25e-05	0.00173	CbGpPWpGaD
Estramustine—Diarrhoea—Methotrexate—urinary bladder cancer	2.24e-05	0.000904	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	2.23e-05	0.00172	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	2.19e-05	0.00169	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	2.18e-05	0.00168	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	2.18e-05	0.00168	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.18e-05	0.00168	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.17e-05	0.00167	CbGpPWpGaD
Estramustine—Pruritus—Epirubicin—urinary bladder cancer	2.17e-05	0.000875	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	2.16e-05	0.00167	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	2.14e-05	0.00165	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	2.14e-05	0.00165	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	2.13e-05	0.00164	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	2.12e-05	0.00163	CbGpPWpGaD
Estramustine—Diarrhoea—Epirubicin—urinary bladder cancer	2.1e-05	0.000846	CcSEcCtD
Estramustine—Vomiting—Methotrexate—urinary bladder cancer	2.08e-05	0.00084	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	2.08e-05	0.0016	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	2.07e-05	0.0016	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.07e-05	0.0016	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	2.07e-05	0.00159	CbGpPWpGaD
Estramustine—Rash—Methotrexate—urinary bladder cancer	2.06e-05	0.000833	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—urinary bladder cancer	2.06e-05	0.000832	CcSEcCtD
Estramustine—Headache—Methotrexate—urinary bladder cancer	2.05e-05	0.000828	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	2.03e-05	0.00157	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	2.03e-05	0.00156	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.01e-05	0.00155	CbGpPWpGaD
Estramustine—Pruritus—Doxorubicin—urinary bladder cancer	2.01e-05	0.00081	CcSEcCtD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	2e-05	0.00154	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	1.98e-05	0.00152	CbGpPWpGaD
Estramustine—Vomiting—Epirubicin—urinary bladder cancer	1.95e-05	0.000786	CcSEcCtD
Estramustine—Nausea—Methotrexate—urinary bladder cancer	1.94e-05	0.000785	CcSEcCtD
Estramustine—Diarrhoea—Doxorubicin—urinary bladder cancer	1.94e-05	0.000783	CcSEcCtD
Estramustine—Rash—Epirubicin—urinary bladder cancer	1.93e-05	0.00078	CcSEcCtD
Estramustine—Dermatitis—Epirubicin—urinary bladder cancer	1.93e-05	0.000779	CcSEcCtD
Estramustine—Headache—Epirubicin—urinary bladder cancer	1.92e-05	0.000775	CcSEcCtD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	1.91e-05	0.00147	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	1.9e-05	0.00146	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	1.89e-05	0.00146	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	1.84e-05	0.00142	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	1.84e-05	0.00141	CbGpPWpGaD
Estramustine—Nausea—Epirubicin—urinary bladder cancer	1.82e-05	0.000735	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	1.81e-05	0.00139	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.8e-05	0.00139	CbGpPWpGaD
Estramustine—Vomiting—Doxorubicin—urinary bladder cancer	1.8e-05	0.000728	CcSEcCtD
Estramustine—Rash—Doxorubicin—urinary bladder cancer	1.79e-05	0.000721	CcSEcCtD
Estramustine—Dermatitis—Doxorubicin—urinary bladder cancer	1.79e-05	0.000721	CcSEcCtD
Estramustine—Headache—Doxorubicin—urinary bladder cancer	1.78e-05	0.000717	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.76e-05	0.00136	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	1.76e-05	0.00136	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	1.76e-05	0.00135	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.73e-05	0.00133	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—ESR1—urinary bladder cancer	1.72e-05	0.00133	CbGpPWpGaD
Estramustine—Nausea—Doxorubicin—urinary bladder cancer	1.68e-05	0.00068	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.68e-05	0.0013	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	1.67e-05	0.00129	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.67e-05	0.00128	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	1.6e-05	0.00123	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	1.58e-05	0.00121	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PPARG—urinary bladder cancer	1.57e-05	0.00121	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SMC1A—urinary bladder cancer	1.57e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	1.54e-05	0.00119	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	1.53e-05	0.00118	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	1.53e-05	0.00118	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	1.51e-05	0.00117	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	1.51e-05	0.00116	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	1.51e-05	0.00116	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.48e-05	0.00114	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	1.43e-05	0.0011	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.43e-05	0.0011	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	1.37e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	1.32e-05	0.00102	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	1.32e-05	0.00101	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	1.31e-05	0.00101	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	1.31e-05	0.00101	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	1.29e-05	0.000996	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	1.28e-05	0.000989	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	1.28e-05	0.000984	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	1.26e-05	0.000971	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	1.26e-05	0.000967	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.25e-05	0.000963	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	1.25e-05	0.000961	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	1.24e-05	0.000955	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	1.21e-05	0.000935	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	1.19e-05	0.000918	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.13e-05	0.000874	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	1.11e-05	0.000852	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	1.1e-05	0.000846	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.1e-05	0.000845	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.09e-05	0.000844	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	1.07e-05	0.000827	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	1.07e-05	0.000823	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	1.06e-05	0.000814	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NCOR1—urinary bladder cancer	1.06e-05	0.000814	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.04e-05	0.000804	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.02e-05	0.000785	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.02e-05	0.000782	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	1.01e-05	0.000782	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	1.01e-05	0.000778	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ERCC2—urinary bladder cancer	9.93e-06	0.000765	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	9.33e-06	0.000719	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	9.29e-06	0.000716	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	9.25e-06	0.000713	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	9.25e-06	0.000713	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	9.1e-06	0.000701	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	9.09e-06	0.0007	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	9.02e-06	0.000695	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—urinary bladder cancer	8.96e-06	0.000691	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.9e-06	0.000686	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.59e-06	0.000662	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	8.58e-06	0.000661	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	8.54e-06	0.000658	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	8.47e-06	0.000653	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.47e-06	0.000653	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.41e-06	0.000648	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ESR1—urinary bladder cancer	8.3e-06	0.000639	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	8.11e-06	0.000625	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	8.1e-06	0.000624	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NAT1—urinary bladder cancer	8.1e-06	0.000624	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	8.01e-06	0.000617	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	7.93e-06	0.000611	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SMC1A—urinary bladder cancer	7.91e-06	0.00061	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.89e-06	0.000608	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.78e-06	0.0006	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	7.75e-06	0.000597	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	7.62e-06	0.000587	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPARG—urinary bladder cancer	7.57e-06	0.000583	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.47e-06	0.000576	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	7.4e-06	0.000571	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CREBBP—urinary bladder cancer	7.27e-06	0.00056	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ESR2—urinary bladder cancer	6.9e-06	0.000531	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.88e-06	0.00053	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.79e-06	0.000523	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	6.67e-06	0.000514	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	6.64e-06	0.000512	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	6.3e-06	0.000485	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	6.14e-06	0.000473	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6e-06	0.000462	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.81e-06	0.000447	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.79e-06	0.000446	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.52e-06	0.000426	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.37e-06	0.000414	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NCOR1—urinary bladder cancer	5.33e-06	0.00041	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	5.31e-06	0.000409	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.26e-06	0.000405	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ERCC2—urinary bladder cancer	5.01e-06	0.000386	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	5e-06	0.000385	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.99e-06	0.000384	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.99e-06	0.000384	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.91e-06	0.000378	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.81e-06	0.000371	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	4.76e-06	0.000366	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.71e-06	0.000363	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.56e-06	0.000352	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	4.52e-06	0.000348	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.48e-06	0.000345	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.45e-06	0.000343	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.44e-06	0.000342	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—urinary bladder cancer	4.32e-06	0.000332	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.11e-06	0.000317	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.95e-06	0.000305	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.88e-06	0.000299	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—S100B—urinary bladder cancer	3.85e-06	0.000297	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.83e-06	0.000295	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPARG—urinary bladder cancer	3.82e-06	0.000294	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.78e-06	0.000291	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CREBBP—urinary bladder cancer	3.67e-06	0.000283	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.55e-06	0.000273	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.55e-06	0.000273	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	3.46e-06	0.000267	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.44e-06	0.000265	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.22e-06	0.000248	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—urinary bladder cancer	3.05e-06	0.000235	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.02e-06	0.000233	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.86e-06	0.00022	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.8e-06	0.000216	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.73e-06	0.000211	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.38e-06	0.000184	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	2.38e-06	0.000184	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.36e-06	0.000182	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	2.35e-06	0.000181	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.22e-06	0.000171	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.19e-06	0.000169	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.19e-06	0.000169	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.18e-06	0.000168	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.18e-06	0.000168	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—urinary bladder cancer	2.18e-06	0.000168	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	2.16e-06	0.000166	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.12e-06	0.000163	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.1e-06	0.000162	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.06e-06	0.000159	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	2e-06	0.000154	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.94e-06	0.000149	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.89e-06	0.000146	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.81e-06	0.000139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.76e-06	0.000136	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.76e-06	0.000136	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.71e-06	0.000132	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.71e-06	0.000131	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.7e-06	0.000131	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.62e-06	0.000125	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.58e-06	0.000122	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.57e-06	0.000121	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.51e-06	0.000116	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.47e-06	0.000113	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.41e-06	0.000109	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.38e-06	0.000107	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.37e-06	0.000105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.35e-06	0.000104	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.35e-06	0.000104	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.31e-06	0.000101	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.29e-06	9.96e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.27e-06	9.78e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.24e-06	9.52e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.19e-06	9.19e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—urinary bladder cancer	1.16e-06	8.95e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	1.11e-06	8.56e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.08e-06	8.3e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.03e-06	7.92e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.67e-07	7.45e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.29e-07	7.16e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.61e-07	5.86e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.64e-07	5.11e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.33e-07	4.88e-05	CbGpPWpGaD
